As of November 10, 2026, Myomo, Inc. is a publicly traded company (NYSE: MYO). The largest holder reporting an active stake on Schedule 13D is Horton Capital Partners, LLC, at 6%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Rosalind Advisors, Inc. (9.9%) (Schedule 13D/A, May 18, 2026).
Is this your company?
About to sign with, pay or invest in Myomo, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Myomo, Inc. a real, registered company?
- Myomo, Inc. files with the SEC under CIK 1369290 (its SEC filings).
- Its shares are listed under the ticker MYO on NYSE (SEC company record).
- Incorporated in Delaware; business address in Boston, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under MYOMO, INC. in our court records and SEC 8-K records (as of 2026-11-10).
- Leadership changes: the latest reported is William J. Febbo (Form 8-K filed 2026-04-16). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Rosalind Advisors, Inc. (filed 2026-08-12).
Who are Myomo, Inc.'s owners and officers?
Myomo, Inc.: incorporated in Delaware; business address in Boston, Massachusetts; industry Orthopedic, Prosthetic & Surgical Appliances & Supplies (Schedule 13G/A, 2026-08-12).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-12 | Rosalind Advisors, Inc. | 9.9% |
| Schedule 13D/A, 2026-05-18 | Horton Capital Partners, LLC | 6% |
| Schedule 13G/A, 2026-02-11 | Rosalind Advisors, Inc. | 9.9% |
| Schedule 13D, 2025-12-29 | Horton Capital Partners, LLC | 5.1% |
| Schedule 13G/A, 2025-11-12 | Rosalind Advisors, Inc. | 9.9% |
| Schedule 13G/A, 2025-11-10 | Orin Hirschman | 1.3% |
| Schedule 13G/A, 2025-08-11 | Rosalind Advisors, Inc. | 9.9% |
Questions about who owns Myomo, Inc.
Who owns Myomo, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Myomo, Inc.: Rosalind Advisors, Inc. (9.9%, Schedule 13G/A, filed 2026-08-12) and Horton Capital Partners, LLC (6%, Schedule 13D/A, filed 2026-05-18).
Who are the largest shareholders of Myomo, Inc.?
By the share each holder's latest filing reports, the largest holders of Myomo, Inc. on this page are Rosalind Advisors, Inc. (9.9%) and Horton Capital Partners, LLC (6%).
When did Rosalind Advisors, Inc. buy into Myomo, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Rosalind Advisors, Inc. on this page is the Schedule 13G/A, filed 2025-08-11, reporting 9.9%; its latest, Schedule 13G/A filed 2026-08-12, reports 9.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Myomo, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Myomo, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Myomo, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-04-16 | William J. Febbo | appointed | 2026-04-14 | |
| Form 8-K, 2026-04-16 | William J. Febbo | Director | appointed |
Which insiders own Myomo, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 1,514,292 shares (3.8% of shares outstanding) (Form 4, 2026-10-15).
- , a director: 772,569 shares (1.9% of shares outstanding) (Form 4, 2026-06-26).
- , the chief financial officer: 549,862 shares (1.4% of shares outstanding) (Form 4, 2026-10-15).
- , the chief commericial officer: 275,000 shares (0.69% of shares outstanding) (Form 4, 2026-10-13).
- , a director: 210,458 shares (0.52% of shares outstanding) (Form 4, 2026-06-26).
Shares outstanding: 40,099,174 as of 2026-11-03, from the company's latest SEC cover page.
How much has Myomo, Inc. raised?
No fundraising or offering filing from Myomo, Inc. is on file with us.
Keep reading
More on Myomo, Inc. and the records around it.
Myomo, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Leadership changes Jun 2026
Companies that share a holder
- Horton Capital Partners Fund, LP also filed stake reports on 1 other company: KORU Medical Systems, Inc. (Feb 2026)
- Rosalind Advisors, Inc. also filed stake reports on 11 other companies: DELCATH SYSTEMS, INC. (Oct 2026), FEMASYS INC (Aug 2026), FENNEC PHARMACEUTICALS INC. (Aug 2026)
- Orin Hirschman also filed stake reports on 46 other companies: ASPEN AEROGELS, INC. (Oct 2026), Bionano Genomics, Inc. (Oct 2026), FENNEC PHARMACEUTICALS INC. (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/myomo